NATERA, INC. Cost of Revenue
NATERA, INC. (NTRA) reported Cost of Revenue of $42.73 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-07.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2020-08-07
- NATERA, INC. cost of goods and services sold for the quarter ending 2020-06-30 was $42.73M, a 3.26% increase year-over-year.
- NATERA, INC. cost of goods and services sold for the quarter ending 2020-03-31 was $41.52M, a 0.20% decline year-over-year.
- NATERA, INC. cost of goods and services sold for the quarter ending 2019-09-30 was $40.14M, a 1.67% increase year-over-year.
- NATERA, INC. cost of goods and services sold for the quarter ending 2019-06-30 was $41.38M, a 5.56% increase year-over-year.
- NATERA, INC. cost of goods and services sold for fiscal 2018 was $158.08M, a 16.66% increase from fiscal 2017.
- NATERA, INC. cost of goods and services sold for fiscal 2017 was $135.51M, a 0.75% increase from fiscal 2016.
- NATERA, INC. cost of goods and services sold for fiscal 2016 was $134.49M.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|
| 2020-06-30 | $42.73M 10-Q · filed 2020-08-07 | $84.25M 10-Q · filed 2020-08-07 | ||
| 2020-03-31 | $41.52M 10-Q · filed 2020-05-08 | |||
| 2019-09-30 | $40.14M 10-Q · filed 2019-11-08 | $81.52M derived: sum of 2 quarters · filed 2020-08-07 | $123.13M 10-Q · filed 2019-11-08 | $163.47M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-06-30 | $41.38M 10-Q · filed 2020-08-07 | $82.99M 10-Q · filed 2020-08-07 | $123.33M derived: sum of 3 quarters · filed 2020-08-07 | $162.81M derived: sum of 4 quarters · filed 2020-08-07 |
| 2019-03-31 | $41.60M 10-Q · filed 2020-05-08 | $81.95M derived: sum of 2 quarters · filed 2020-05-08 | $121.43M derived: sum of 3 quarters · filed 2020-05-08 | $160.63M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $40.34M 10-K · filed 2019-03-15 | $79.82M derived: sum of 2 quarters · filed 2019-11-08 | $119.03M derived: sum of 3 quarters · filed 2019-11-08 | $158.08M 10-K · filed 2019-03-15 |
| 2018-09-30 | $39.48M 10-Q · filed 2019-11-08 | $78.68M derived: sum of 2 quarters · filed 2019-11-08 | $117.74M 10-Q · filed 2019-11-08 | $152.89M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $39.20M 10-Q · filed 2019-08-09 | $78.26M 10-Q · filed 2019-08-09 | $113.41M derived: sum of 3 quarters · filed 2019-08-09 | $146.97M derived: sum of 4 quarters · filed 2019-08-09 |
| 2018-03-31 | $39.05M 10-Q · filed 2019-05-10 | $74.21M derived: sum of 2 quarters · filed 2019-05-10 | $107.77M derived: sum of 3 quarters · filed 2019-05-10 | $141.47M derived: sum of 4 quarters · filed 2019-05-10 |
| 2017-12-31 | $35.15M 10-K · filed 2019-03-15 | $68.71M derived: sum of 2 quarters · filed 2019-03-15 | $102.42M derived: sum of 3 quarters · filed 2019-03-15 | $135.51M 10-K · filed 2019-03-15 |
| 2017-09-30 | $33.56M 10-K · filed 2019-03-15 | $67.27M derived: sum of 2 quarters · filed 2019-03-15 | $100.36M 10-Q · filed 2018-11-09 | |
| 2017-06-30 | $33.71M 10-K · filed 2019-03-15 | $66.80M derived: sum of 2 quarters · filed 2019-03-15 | ||
| 2017-03-31 | $33.09M 10-K · filed 2019-03-15 | |||
| 2016-12-31 | $134.49M 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |